Hill Holler

Raw Political Coverage and Opinions

Home /
Cameron Clokie Advances Into Regenerative Medicine Sector
;

Cameron Clokie Advances Into Regenerative Medicine Sector

In the recent past, regenerative medicine has been famous and acceptable by many patients across the world. This is why, biomaterials, molecules, and cells have been donated and transplanted to patients to cure existing injuries and disorders. However, there is a wide gap in the regenerative medicine sector to meet the world’s high demand for cell transplant. Furthermore, regenerative medicine hasn’t been major medical treatment practice in most areas of medicine.

The earliest mode of cell therapy was blood transfusion which is popular in numerous clinics. It was followed by bone marrow transplantation that applied the bone marrow stem cells from a donor to victims of blood cancer. Cell therapy enabled a patient with severe burn injuries and scalds to have a transplant and heal from the injury. Additionally, it produces extraordinary clinical outputs that saves thousands of patients.

The Toronto Surgeon and regenerative medicine professional, Dr. Cameron Clokie, is a serial entrepreneur, a scientist, a maxillofacial and oral surgeon. Dr. Clokie is the Induce Biologics Inc’s Chief Executive Officer that provides innovative solutions for reconstruction of musculoskeletal. He joined McGill University obtained a Doctor Dental Surgery in 1985 and a Bone Regeneration doctorate (Ph.D.). He has engaged in clinical practice and academic dentistry for over 3 decades. Furthermore, he served in various positions on the scientific advisory boards in numerous companies.

In 1998, Cameron Clokie became the Head of Oral and Maxillofacial Surgery and the Oral and Maxillofacial Surgery Professor at the University of Toronto. He made numerous international and national presentations and published numerous papers on regenerative medicine and bone reconstruction. Dr. Cameron Clokie presented the Health and Longevity, Science and Technology that focused on the future of regenerative medicine in 2006.

In 2017, Cameron Clokie retired from academics and focus on his company; Induce Biologics Inc. He successfully collaborated with enterprises to remit his regenerative medicine knowledge into commercially feasible businesses. He has handled numerous surgeries and saved the lives of thousands of patients that needed cell therapy. Dr. Clokie practices the full scope of the specialty of Oral and Maxillofacial Surgery.